Starpharma Holdings Health Care
Biotech Cancer Healthcare Pharmaceuticals

$0.310 0.030 (10.71%)

High $0.31	Low $0.29	Trades 582	Turnover $291,413	Volume 965,700
30 June 2023 at 4:10pm

Market Cap (23-Oct) $223,078,688 (436th)	Close (30-Jun) $0.310 0 (0%)	Volume (30-Jun) 965,700	Shortsold (19-Oct) 234,456 (0.05%) (486th)
52w High $0.88	52w Low $0.305	P/E 312.50	EPS -0.02

Short Interest

ASIC data, 19 Oct 2026

% Shorted

0.05%

vs 0.05% prior report

Most Shorted Rank

486th

of 703 shorted ASX stocks

Peak Short

5.92%

Sep 2013

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	SPL SPL Ann: Change in substantial holding
	1 (current) 2 3
	SPL SPL Article: Equity Markets \| Latest News & Analysis \| The Australian Financial ...
	SPL SPL Article: Topic \| Capital raising \| Australian Financial Review
	SPL SPL Article: Companies \| Latest News & Analysis \| The Australian Financial ...
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: VIRALEZE COVID-19 nasal spray study to commence in January
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: VIRALEZE COVID-19 nasal spray to be ready for market Q1CY21
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Appendix 3G
	SPL SPL Ann: Retirement of non-executive director Richard Hazleton
	SPL SPL Ann: 2020 AGM Results
	SPL SPL Ann: AGM Chairman address and CEO presentation
	SPL SPL Ann: SPL7013 shows potent antiviral activity in RSV
	SPL SPL Ann: Appendix 3G
	SPL SPL Ann: Change in Director's Interest Notice - R Thomas
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Change in Director's Interest Notice - Peter Turvey
	SPL SPL Ann: Change in Director's Interest Notice - Peter Turvey
	SPL SPL Ann: Appendix 2A
	SPL SPL Ann: Appendix 2A
	SPL SPL Ann: Quarterly Cashflow and Activities Report
	SPL SPL Ann: Completion of Placement and SPP raises $48.9M in total
	SPL SPL Ann: Starpharma receives $5.7M R&D tax incentive refund
	SPL SPL Ann: Shareholder Update October 2020
	SPL SPL Ann: Notice of Annual General Meeting/Proxy Form

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

End of Day Prices

Date	Close	Volume	Change
23-Oct	$0.47	1,528,036	0.00 (1.06%)
22-Oct	$0.47	3,326,752	-0.01 (2.08%)
21-Oct	$0.48	6,005,409	-0.02 (4.00%)
20-Oct	$0.50	10,307,969	-0.25 (33.33%)
19-Oct	$0.75	0	0.00 (0.00%)
16-Oct	$0.75	0	0.00 (0.00%)
15-Oct	$0.75	2,420,375	-0.05 (6.25%)
14-Oct	$0.80	1,148,946	-0.03 (3.61%)
13-Oct	$0.83	2,209,167	-0.02 (2.35%)
12-Oct	$0.85	2,594,664	+0.01 (0.59%)
09-Oct	$0.85	2,438,535	+0.01 (1.20%)
08-Oct	$0.84	1,291,818	+0.01 (0.60%)
07-Oct	$0.83	1,870,722	+0.02 (1.84%)
06-Oct	$0.82	2,640,252	+0.00 (0.62%)
05-Oct	$0.81	1,877,109	+0.01 (1.25%)
6 up, 7 down, and 2 flat days

Starpharma Holdings Health Care
Biotech Cancer Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Starpharma Holdings Health Care Biotech Cancer Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Starpharma Holdings Health Care
Biotech Cancer Healthcare Pharmaceuticals